Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_assertion type Assertion NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_head.
- NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_assertion description "[The authors conclude that, although the TEL/AML1 positive leukemias generally are associated with a favorable outcome, MRD positivity assessed by RQ-RT-PCR analysis at the end of induction therapy represents a significantly negative prognostic feature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_provenance.
- NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_assertion evidence source_evidence_literature NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_provenance.
- NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_assertion SIO_000772 12491511 NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_provenance.
- NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_assertion wasDerivedFrom befree-20150227 NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_provenance.
- NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_assertion wasGeneratedBy ECO_0000203 NP285411.RAcPqsLXm4Zcexeh0l-uLACJiu2ZlBCfwrcA_5Ch_9l3Q130_provenance.